Subcortical Heterotopia:A Distinct Clinicoradiologic Entity
AJNR 17:1315-1322, Barkovich,A.J., 1996
Long-Term Tacrine (Cognex) Treatment:Effects on Nursing Home Placement and Mortality
Neurol 47:166-177, Knopman,D.,et al, 1996
Progressive Ataxia, Focal Seizures, and Malabsorption Syndrome in a 41 Year Old Woman
JNNP 60:225-230, Mumford,C.J.,et al, 1996
The Impact of New Pharmaceutical Agents on the Cost of Neurologic Care
Neurol 45:569-572, Gunderson,C.H., 1995
Tacrine
Lancet 345:625-630, Davis,K.L.&Powchik,P., 1995
Hepatotoxic Effects of Tacrine Administration in Patients with Alzheimer's Disease
JAMA 271:992-998, Watkins,P.B.,et al, 1994
30-Week Randomized Controlled Trial of High-Dose Tacrine in Patients with Alzheimer's Disease
JAMA 271:985-991, 10231994., Knapp,M.J.,et al, 1994
Efficacy of Tacrine and Lecthin in Mild to Moderate Alzheimer's Disease:Double Blind Trial
BMJ 308:879-883, Maltby,N.,et al, 1994
Short-term Night Blindness Associated with Colon Resection and Hypovitaminosis A
Arch Ophthalmol 112:162-163, Sloan,D.B.,et al, 1994
A Controlled Trial of Tacrine in Alzheimer's Disease
JAMA 268:2523-2529, 25641992., Farlow,M.,et al, 1992
A Double-Blind, Placebo-Controlled Multicenter Study of Tacrine for Alzheimer's Dissease
NEJM 327:1253-1259, 13061992., Davis,K.L.,et al, 1992
Nerve Agents:A Review
Neurol 42:946-950, Gunderson,C.H.,et al, 1992
Pyridostigmine Used as a Nerve Agent Pretreatment Under Wartime Conditions
JAMA 266:693-695, Keeler,J.R.,et al, 1991
Abnormal Vitamin B12 Metabolism in Human Immunodeficiency Virus Infection
Arch Neurol 48:312-314, Kieburtz,K.D.,et al, 1991
Management of Injuries Due to Chemical Weapons
BMJ 302:129-130, Murray,V.S.G.&Volans,G.N., 1991
Tacrine in Alzheimer's Disease
Lancet 337:989-992, Eagger,S.A.,et al, 1991
Tetrahydroaminoacridine-Lecithin Combination Treatment in Patients with Intermediate-Stage Alzheimer's Disease
NEJM 322:1272-1276, Gauthier,S.,et al, 1990
Tacrine (tetrahydroaminoacridine; THA) and Lecithin in Senile Dememtia of the Alzheimer Type:A Multicentre Trial
BMJ 300:495-499, Chatellier,G.,et al, 1990
Tetrahydroaminoacridine (THA) in Alzheimer's Disease, Not Ready for Routine Use
BMJ 298:845-846, Graham,T.R.&Lewis,C.T., 1989
Long-Term Administration of Oral Physostigmine in Alzheimer's Disease
Neurol 38:1837-1841, Stern,Y.,et al, 1988
Neuropsychiatric Disorders Caused by Cobalamin Deficiency in the Absence of Anemia or Macrocytosis
NEJM 318:1720-1728, 1752-17541988., Lindenbaum,J.,et al, 1988
Distal Axonopathy Associated with Chronic Gluten Enteropathy:A Treatable Disorder
Neurol 38:642-645, Kaplan,J.G.,et al, 1988
Hypoparathyroidism
Cecil Textbook of Medicine 18th Ed, W B Saunders Co, Phila, p149688., Arnaud,C.D., 1988
Effects of Oral Physostigmine in Alzheimer's Disease
Ann Neurol 22:306-310, Stern,Y.,et al, 1987
Physostigmine Improves ECT-Induced Memory Disturbances
Neurol 37:871-875, Levin,Y.,et al, 1987
Positive Response to Edrophonium in Patients with Neurotoxic Envenoming by Cobras (NAJA NAJA PHILIPPINENIS)
NEJM 315:1444-1448, Watt,G.,et al, 1986
Oral Tetrahydroaminoacridine in Long-Term Treatment of Senile Dementia, Alzheimer Type
NEJM 315:1241-1245, Summers,W.K.,et al, 1986
Celiac Disease & Spinocerebellar Degeneration with Normal Vitamin E Status
Neurol 35:1199-1201, Ward,M.E.,et al, 1985
Improved Neurologic Function After Long-Term Correction of Vitamin E Deficiency in Children with Chronic Cholestasis
NEJM 313:1580-1586, Sokol,R.J.,et al, 1985
Blind Loop Syndrome, Vitamin E Malabsorption, & Spinocerebellar Degeneration
Neurol 35:338-342, Brin,M.F.,et al, 1985
Neurologic Disorder of Vitamin E Deficiency in Acquired Intestinal Malabsorption
Neurol 34:1561-1565, Weder,B.,et al, 1984
Drug-Induced Seizures:A 10-Year Experience
Neurol 34:1582-1586, Messing,R.O.,et al, 1984
Memory Enhancement with Oral Physostigmine in Alzheimer's Disease
NEJM 308:720-721, Thal,L.J.,et al, 1983
Oral Physostigmine & Lecithin Improve Memory in Alzheimer Disease
Ann Neurol 13:491-496, Thal,L.J.,et al, 1983
Memory Decline in the Aged:Treatment with Lecithin & Physostigmine
Neurol 32:944-950, Drachman,D.A.,et al, 1982
Spinocerebellar Degeneration Secondary to Chronic Intestinal Malabsorption:A Vitamin E Deficiency Syndrome
Ann Neurol 12:419-424, Harding,A.E.,et al, 1982
Amitriptyline-induced Ophthalmoplegia
Neurol 31:1188-1190, Spector,R.H.,et al, 1981
Association Of Spinocerebellar Disorders With Cystic Fibrosis Or Chronic Childhood Cholestasis & Very Low Serum Vit. E
Lancet 2:1319-1321, Elias,E.,et al, 1981
Double-blind, Triple-crossover Trial of Low Doses of Oral Physostigmine in Inherited Ataxias
Neurol 31:288-292, Kark,R.A.P.,et al, 1981
Adult Celiac Disease Presenting as Cerebellar Syndrome
Neurol 30:245-249 1980., Finelli,P.F.,et al, 1980
Physostigmine In Gilles De La Tourettes Syndrome
NEJM 302:298, Stahl,S.M.,et al, 1980
Memory & Cognitive Function in the Elderly, A Preliminary Trial of Physostigmine
Arch Neurol 37:674-675, Drachman,D.A.,et al, 1980
Cerebral Thrombosis in Two Patients with Malabsorption Syndrome Treated with Vitamin K
BMJ 281:541, Florholmen,J.,et al, 1980
Abetalipoproteinemia, Report of Two Cases & Review of Therapy
Arch Neurol 37:659-662, Illingworth,D.R.,et al, 1980
Anticholinergic Toxicity
NEJM 300:1278, Caine,E.D., 1979
Physostigmine in Reye Syndrome
Ann Neurol 5:105, Pettegrew,J.W.,et al, 1979
Effects of Physostigmine & Lecithin on Memory in Alzheimer Disease
Ann Neurol 6:219-221, Peters,B.H.,et al, 1979
Enhancement Of Memory By Physostigmine
NEJM 301:946, Davis,K.L.,et al, 1979
Meige Disease:Striatal Dopaminergic Preponderance
Neurol 29:1126-1130, Tolosa,E.S.,et al, 1979
Reversibility of Human Myopathy Caused by Vitamin E Deficiency
Neurol 29:1182-1186, Tomasi,L.G., 1979